197 related articles for article (PubMed ID: 24035849)
1. Persistence and reappearance of high-risk human papillomavirus after conization.
Gosvig CF; Huusom LD; Andersen KK; Iftner A; Cederkvist L; Svare E; Iftner T; Kjaer SK
Gynecol Oncol; 2013 Dec; 131(3):661-6. PubMed ID: 24035849
[TBL] [Abstract][Full Text] [Related]
2. Age-specific predictors of cervical dysplasia recurrence after primary conization: analysis of 3,212 women.
Bogani G; Pinelli C; Chiappa V; Martinelli F; Lopez S; Ditto A; Raspagliesi F
J Gynecol Oncol; 2020 Sep; 31(5):e60. PubMed ID: 32808492
[TBL] [Abstract][Full Text] [Related]
3. Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3.
Kreimer AR; Katki HA; Schiffman M; Wheeler CM; Castle PE;
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):11-6. PubMed ID: 17220326
[TBL] [Abstract][Full Text] [Related]
4. Nomogram-based prediction of cervical dysplasia persistence/recurrence.
Bogani G; Tagliabue E; Ferla S; Martinelli F; Ditto A; Chiappa V; Leone Roberti Maggiore U; Taverna F; Lombardo C; Lorusso D; Raspagliesi F
Eur J Cancer Prev; 2019 Sep; 28(5):435-440. PubMed ID: 30489353
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of high-risk HPV persistence after laser CO2 conization for high-grade CIN: a prospective clinical study.
Fallani MG; Penna C; Marchionni M; Bussani C; Pieralli A; Andersson KL; Fambrini M
Eur J Gynaecol Oncol; 2008; 29(4):378-82. PubMed ID: 18714574
[TBL] [Abstract][Full Text] [Related]
6. PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia.
Fambrini M; Penna C; Pieralli A; Bussani C; Fallani MG; Andersson KL; Scarselli G; Marchionni M
Gynecol Oncol; 2008 Apr; 109(1):59-64. PubMed ID: 18255129
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia.
Kudoh A; Sato S; Itamochi H; Komatsu H; Nonaka M; Sato S; Chikumi J; Shimada M; Oishi T; Kigawa J; Harada T
Int J Clin Oncol; 2016 Jun; 21(3):580-7. PubMed ID: 26614089
[TBL] [Abstract][Full Text] [Related]
8. [Association between high risk human papillomavirus DNA load and cervical lesions in different infection status].
Li TY; Wu ZN; Jiang MY; Cui JF; Liu B; Chen F; Chen W
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):475-480. PubMed ID: 29936777
[No Abstract] [Full Text] [Related]
9. The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia.
Spinillo A; Dominoni M; Boschi AC; Cesari S; Fiandrino G; Gardella B
Gynecol Oncol; 2020 Dec; 159(3):630-635. PubMed ID: 33041069
[TBL] [Abstract][Full Text] [Related]
10. The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization.
Park JY; Lee KH; Dong SM; Kang S; Park SY; Seo SS
Gynecol Oncol; 2008 Mar; 108(3):549-54. PubMed ID: 18177929
[TBL] [Abstract][Full Text] [Related]
11. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia.
Almog B; Gamzu R; Kuperminc MJ; Levin I; Fainaru O; Niv J; Bar-Am A
Gynecol Oncol; 2003 Mar; 88(3):345-50. PubMed ID: 12648585
[TBL] [Abstract][Full Text] [Related]
12. Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization.
Costa S; De Simone P; Venturoli S; Cricca M; Zerbini ML; Musiani M; Terzano P; Santini D; Cristiani P; Syrjänen S; Syrjänen K
Gynecol Oncol; 2003 Aug; 90(2):358-65. PubMed ID: 12893200
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for human papillomavirus persistence among women undergoing cold-knife conization for treatment of high-grade cervical intraepithelial neoplasia.
Baser E; Ozgu E; Erkilinc S; Togrul C; Caglar M; Gungor T
Int J Gynaecol Obstet; 2014 Jun; 125(3):275-8. PubMed ID: 24726620
[TBL] [Abstract][Full Text] [Related]
14. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?
Nagai Y; Maehama T; Asato T; Kanazawa K
Gynecol Oncol; 2000 Nov; 79(2):294-9. PubMed ID: 11063660
[TBL] [Abstract][Full Text] [Related]
15. Persistent HPV infection after conization in patients with negative margins.
Song SH; Lee JK; Oh MJ; Hur JY; Na JY; Park YK; Saw HS
Gynecol Oncol; 2006 Jun; 101(3):418-22. PubMed ID: 16386782
[TBL] [Abstract][Full Text] [Related]
16. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.
Dalstein V; Riethmuller D; Prétet JL; Le Bail Carval K; Sautière JL; Carbillet JP; Kantelip B; Schaal JP; Mougin C
Int J Cancer; 2003 Sep; 106(3):396-403. PubMed ID: 12845680
[TBL] [Abstract][Full Text] [Related]
17. Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix.
Kong TW; Son JH; Chang SJ; Paek J; Lee Y; Ryu HS
Gynecol Oncol; 2014 Dec; 135(3):468-73. PubMed ID: 25284039
[TBL] [Abstract][Full Text] [Related]
18. Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment.
Venturoli S; Ambretti S; Cricca M; Leo E; Costa S; Musiani M; Zerbini M
J Med Virol; 2008 Aug; 80(8):1434-40. PubMed ID: 18551620
[TBL] [Abstract][Full Text] [Related]
19. Is therapeutic conization sufficient to eliminate a high-risk HPV infection of the uterine cervix? A clinicopathological analysis.
Bodner K; Bodner-Adler B; Wierrani F; Kimberger O; Denk C; Grünberger W
Anticancer Res; 2002; 22(6B):3733-6. PubMed ID: 12552985
[TBL] [Abstract][Full Text] [Related]
20. Predictors of absence of cervical intraepithelial neoplasia in the conization specimen.
Rodriguez-Manfredi A; Alonso I; del Pino M; Fusté P; Torné A; Ordi J
Gynecol Oncol; 2013 Feb; 128(2):271-6. PubMed ID: 23116936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
